Ziehm's Vision RFD Mobile C-Arm Imaging System Cleared by FDA

 

June 10, 2009—Ziehm Imaging, Inc. (Orlando, FL) announced that the US Food and Drug Administration has granted 510(k) marketing clearance for the Ziehm Vision RFD, a mobile C-arm imaging system that is designed for use in endovascular, interventional radiology, and interventional cardiology procedures.

According to the company, the Ziehm Vision RFD combines flat-panel technology with object-detected dose-control software and specially designed anatomical programs for enhanced image quality with a minimal dose of radiation. The 30- X 30-cm flat-panel detector allows for fully digital, distortion-free imaging and better access to the patient due to the larger C-arm opening and the 165¡ orbital rotation. With pulse technology at up to 25 frames per second, the system provides sharp, high-contrast images of vasculature, bone, and soft tissue structures. The 1,500- X 1,500-pixel resolution provides extended dynamic range and 49% greater anatomical viewing compared to 12-inch image intensifier systems delivering comprehensive information about the patient's anatomy. The Ziehm Vision RFD's VisionCenter touchscreen user interface simplifies workflow and improves day-to-day clinical efficiency, the company stated.
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.